Spruce Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Spruce Biosciences

11/05/2022 23:21

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly
adjusted
loss of 50 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 46 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Spruce Biosciences Inc's reported EPS for the quarter was
a loss
of 50 cents​.
    * The mean earnings estimate of analysts had risen by
about 27.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spruce Biosciences Inc shares had fallen by 28.9% this
quarter and lost 67.9% so far this year.
    * The company reported a quarterly loss of $11.76 million.
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 10:21 p.m.  ​All
figures in US dollars unless otherwise stated